Last spring I spent about two hours trying to figure out what a GLP-1 prescription would actually cost me per month. Every site I landed on had a “start your visit” button and a price that only appeared after I’d handed over my email, my credit card details, and apparently my dignity. The compounding market got more complicated in early 2026 after Novo Nordisk’s settlement pushed several platforms toward branded drugs. Prices jumped hard for a lot of people. So here are seven providers where I could actually see a number before I committed.
1. HealthRX
The thing that settled it for me was the pharmacy name. A lot of telehealth platforms ship you a vial from some unnamed lab and you have to take their word for it. HealthRX uses Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot tracking from bench to door. That’s not marketing, it’s a verifiable compliance structure. Compounded semaglutide starts at $99/month, compounded tirzepatide at $149/month, free overnight shipping to all 50 states, physician review within about 24 hours. The SURMOUNT-1 trial data it references for tirzepatide showed roughly 21% body weight reduction at 72 weeks. These are compounded medications, not FDA-approved drugs. But for cash-pay pricing with a named, LegitScript-certified pharmacy behind it, this is the most transparent setup I found.
2. FormBlends
Different angle here. FormBlends publishes actual lab results per product: HPLC purity percentages, mass spec identity confirmation, endotoxin sterility numbers. Not a general “we test our products” statement. Named numbers. If that level of documentation matters to you (and for injectable compounded peptides, it should), this is the place to look. Semaglutide runs around $299, tirzepatide around $349, so the price point is higher than HealthRX. Ships to 47 states, not all 50. It also carries a wider peptide catalog for recovery and longevity under the same clinician model, which is genuinely unusual. You’re paying more, but you’re getting published purity data and a broader formulary in one account.
3. Mochi Health
Board-certified obesity-medicine clinicians, not just general practitioners signing prescriptions. Compounded semaglutide at roughly $99/month, tirzepatide around $199. The monitoring is more involved than bare-bones platforms, which some people want and some find annoying. Worth the look if you want clinical depth alongside a competitive cash price.
4. Henry Meds
Fast. Shipping typically runs 24 to 72 hours from order. Cash-pay compounded GLP-1 starting around $179 to $249 for the first month. Lighter on ongoing monitoring than Mochi. Good fit for someone who just wants the medication moving quickly without a lot of check-in overhead.
5. Hims & Hers
When Novo Nordisk reached its March 2026 settlement, Hims & Hers shifted its formulary to branded medications. Injectable Wegovy is listed around $299/month, oral options around $249, Zepbound around $399. With insurance plus a savings card, some people get down to nearly nothing per month. The path is more complicated than cash-pay, but if you have good insurance, this is where branded-drug pricing gets interesting.
6. Ro Body
Membership starts at $39 for the first month, then roughly $74 to $149 monthly, with medication billed separately. Ro has a dedicated prior-authorization team that works the insurance angle for branded drugs, which is a real differentiator. If you want someone fighting your insurer’s bureaucracy on your behalf, Ro has that infrastructure built in.
7. PlushCare
The cheapest membership on this list at $19.99/month. Carries branded medications with insurance support and offers same-day appointments in many cases. It’s not a GLP-1-specialist platform the way Mochi is, but for someone who already has insurance coverage lined up and just needs a fast, low-overhead prescription visit, it fits.
A brief note: compounded GLP-1 medications are not FDA-approved. All the compounded options above carry that caveat. The FDA issued warning letters to more than 30 telehealth and compounding firms in early 2026, so pharmacy credentials and compliance documentation genuinely matter when you’re choosing a provider.
Common Questions
Does the price shown on a GLP-1 telehealth site actually include the medication?
Not always, and this is where the confusion starts. Ro Body, for example, bills membership and medication separately, so the $39 intro price is just the platform fee. HealthRX and FormBlends quote all-in monthly prices that cover the compounded drug itself. Always check whether the listed number includes the vial or just the clinical visit.
Why does FormBlends cost $200 more per month than HealthRX if both are compounded semaglutide?
The gap comes down to documentation. FormBlends publishes product-specific HPLC purity percentages, mass spec identity results, and endotoxin sterility numbers. HealthRX’s advantage is a named, LegitScript-certified 503A pharmacy with lot tracking. Neither is strictly better; the right choice depends on whether you prioritize published lab data or verifiable pharmacy credentials.
After the Novo Nordisk settlement in March 2026, which providers still offer compounded GLP-1 options?
HealthRX, FormBlends, Mochi Health, and Henry Meds were still operating compounded programs as of 2026. Hims & Hers moved to branded drugs after the settlement. The regulatory picture keeps shifting, so checking a provider’s current formulary page before signing up is worth the 60 seconds it takes.
What does it actually mean for a compounding pharmacy to be 503A certified, and why should I care?
A 503A pharmacy compounds medications for individual patients under a valid prescription and must follow USP-797 sterility standards for injectables. It is not FDA-approved in the same way a drug manufacturer is, but it operates under state board oversight and federal guidelines. When a platform names its 503A pharmacy publicly, you can look it up independently, which matters for injectables.
Is Ro Body’s prior-authorization support actually useful, or is it just a selling point?
It depends entirely on your insurer. Prior authorization for branded GLP-1 drugs like Wegovy or Zepbound can take weeks and requires specific documentation of BMI, comorbidities, and failed prior treatments. Having a dedicated team that knows the submission requirements and follows up on denials is a real time saver for people whose insurers routinely reject first attempts.
Sources
- Federal 503A compounding pharmacy standards and the agency’s 2026 warning letter campaign (FDA.gov)
- Tirzepatide weight-loss outcomes: Jastreboff et al., *New England Journal of Medicine*, 2022
- Semaglutide weight-loss outcomes: Wilding et al., *New England Journal of Medicine*, 2021
- Novo Nordisk settlement announcement, March 9 2026 (Reuters, company press release)
- LegitScript pharmacy certification database (LegitScript.com)
- Hims & Hers public pricing pages, accessed 2026
- Ro Body membership and pricing, public site, 2026
